Jayson Rieger - 05 Nov 2024 Form 3 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role: CEO and President, Director
Signature: /s/ Christopher Hayes, Attorney-in-Fact
Issuer symbol: VRCA
Transactions as of: 05 Nov 2024
Net transactions value: $0
Form type: 3
Filing time: 06 Nov 2024, 20:59:16 UTC
Next filing: 06 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Shares After	Date	Ownership	Footnotes
holding	VRCA	Common Stock	551,928	05 Nov 2024	Direct
holding	VRCA	Common Stock	150	05 Nov 2024	By child
holding	VRCA	Common Stock	2,302	05 Nov 2024	By trust	F1
holding	VRCA	Common Stock	2,301	05 Nov 2024	By trust	F1
holding	VRCA	Common Stock	2,302	05 Nov 2024	By trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person is a co-trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person is a co-trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.